a , b , c , d 8.68 ± 0.20 a , b , c , d ECF (50 mg/kg) 25.17 ± 0.29 a , b , c 27 a , b , d Data are expressed as means ± SEM (n = 6) IL-1, interleukin-1 beta; TNF-, tumor necrosis factor-alpha; 5-LO, 5-lipoxygenase Gastroprotective mechanism of Bauhinia thonningii Schum
Negative control
17.30 ± 0.80 b, c
20.83 ± 0.82 b, c
5.35 ± 0.28 b, c
2.72 ± 0.16 b, c
Ulcer control
73.32 ± 4.84 a, c
80.92 ± 4.74 a, c
28.48 ± 1.10 a, c
20.73 ± 0.75 a, c
ECF (25 mg/kg)
28.83 ± 0.79 a, b, c
38.27 ± 0.94 a, b, c, d
13.70 ± 0.44 a, b, c, d
8.68 ± 0.20 a, b, c, d
ECF (50 mg/kg)
25.17 ± 0.29 a, b, c
27.80 ± 0.54 a, b, c
8.38 ± 0.29 a, b, c
5.05 ± 0.12 a, b, c
ECF (100 mg/kg)
16.60 ± 0.76 b, c, d
20.80 ± 0.82 b, c, d
4.90 ± 0.20 b, c, d
2.30 ± 0.17 b, c, d
Omeprazole (20 mg/kg)
43.00 ± 1.93 a, b, d
50.32 ± 1.74 a, b, d
19.70 ± 0.41 a, b, d
13.25 ± 0.32 a, b, d
Data are expressed as means ± SEM (n = 6). IL-1, interleukin-1 beta; TNF-, tumor necrosis factor-alpha; 5-LO, 5-lipoxygenase; COX-2, cyclooxygenase 2.
a Significantly different from the negative control group at p < 0.05.
b Significantly different from the ulcer control group at p < 0.05.
c Significantly different from the omeprazole group at p < 0.05.
d Significantly different from the corresponding group treated with ECF 50 mg/kg at p < 0.05.
References
Abdelwahab, S.I., Taha, M.M.E., Abdulla, M.A., Nordin, N., Hadi, A.H.A., Mohan, S.,
Jayapalan, J.J., Hashim, O.H., 2013. Gastroprotective mechanism of Bauhinia thonningii Schum. J. Ethnopharmacol. 148, 277–286.